COTA Signs Research Collaboration Agreement With The U.S. Food and Drug Administration
05.29.19
COTA, Inc., a leading precision medicine technology company that uses real-world evidence to bring clarity to cancer care, today announced it has signed a two-year Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA) Information Exchange and Data Transformation (INFORMED) Program, the Agency's data science and technology incubator supporting regulatory science research. This RCA will establish a study protocol with an initial focus on breast cancer, and will provide the FDA with information on the evolving treatment landscape, including insight on treatment variation within defined subpopulations of patients with the disease. As the project advances, the research may expand to other cancer types and explore disease characteristics, treatment patterns, and patient outcomes for the broader application of precision medicine. Read Full Release
COTA to attend ASCO May 31st – June 4th, 2019
05.31.19
Attending #ASCO19 5/31-6/4? Stop by Booth #2063 to learn how COTA organizes fragmented, often hidden data from the real world to provide a clear view of cancer or schedule a demo with us here: meetus@cotahealthcare.comFind more details about the attending here. Read Full Release
Forefront Telecare, Behavioral Health Solution for Rural Americans, Completes $15 Million Growth Equity Funding Round
04.24.19
Boston, MA, April 2019 Boston Millennia Partners IV is pleased to announce its investment in Forefront Telecare, Inc. as part of a $15 million growth equity round. Forefront is a leading provider of behavioral services via Telehealth to vulnerable populations across the country. With a focus on high acuity psychiatric patients in rural markets, Forefront offers services to hospitals, skilled nursing facilities, and clinics that have limited access to behavioral health practitioners. The solution consists of an extensive provider network, a modern video conferencing platform, and scalable in-house billing. The company currently serves over 175 customers and will be relocating headquarters to New Jersey. Read Full Release
Health Decisions Appoints Sheila Kiss as Head of European Clinical Operations
03.31.19
Health Decisions, Inc., the full-service clinical research organization (CRO) of choice for forward-looking biopharma and medical device companies and a leader in women’s health and diagnostics studies, has appointed Sheila Kiss as Head of European Clinical Operations. With more than 35 years’ experience in Clinical Operations and Project Management, Kiss will support Health Decisions’ dedicated Clinical Operations Team to execute research in Women’s Health and In Vitro Diagnostic clinical development. Read Full Release
MEDAPTUS NAMES DR. SUSAN KATZ SLISKI AS CHIEF NURSING OFFICER
02.05.19
Susan Katz Sliski, DNP, RN, CCM, FAAOHN has been named the Chief Nursing Officer (CNO) for MedAptus, Inc. In her role, Dr. Katz Sliski will be working closely with the product management team to promote and improve all MedAptus products, with a special focus on ASSIGN for Nurses, the company’s flagship patient assignment software for nurses. In her most recent role prior to joining MedAptus, Dr. Katz Sliski was leading REDESIGN initiatives within healthcare organizations to improve patient and provider experiences, drive organizational effectiveness and decrease costs. Read Full Release
MedAptus
MEDAPTUS RANKED #1 IN KLAS RANKINGS FOR MOBILE CHARGE CAPTURE IN 2019
01.31.19
“This is one more indication of our commitment towards providing the very best charge management solutions in healthcare,” said Eugene Schneider, MedAptus president and CEO. “Whether it’s for professionals, facilities or even infusion coding services, our charge capture, management and reconciliation processes are consistently finding new sources of revenue for our customers. That’s extremely important as hospitals and other entities continue to tighten belts in this very challenging healthcare environment.” Read Full Release
COTA
HIMSS19: The Importance of Data and Managing Expectations
02.01.19
It’s that time of year again! As we get ready for all that HIMSS has to offer and learn about exciting opportunities in healthcare, it’s important to manage expectations around what is going to be accomplished at the conference. It’s no surprise that HIMSS continues to get bigger and bigger every year, but many of the same things are still being discussed - Artificial Intelligence (AI), Machine Learning, Natural Language Processing, data security and improving efficiencies, to name a few. Read Full Release
To Improve Treatments, Researchers Want To Hunt For Clues In Medical Records
07.15.18
When you go to your doctor's office, sometimes it seems the caregivers spend more time gathering data about you than treating you as a patient. Electronic medical records are everywhere – annoying to doctors and intrusive to patients. But now researchers are looking to see if they can plow through the vast amount of data that's gathered in those records, along with insurance billing information, to tease out the bits that could be useful in refining treatments and identifying new uses for drugs. Read Full Release
COTA
Data sharing company helps improve cancer patient outcomes, reduce total cost of care
07.13.18
Over the years oncologists and health care experts have struggled to find new ways to reduce the cost of cancer treatment. The American Cancer Society estimates patients paid nearly $4 billion in out-of-pocket costs in 2014, and that the disease cost the country around $88 billion in cancer-related health care spending that same year. Some doctors are now looking at emerging oncology data companies to help reduce that financial burden all while improving clinical outcomes. Read Full Release
Health Decisions
US CRO Health Decisions and European CRO/SMO Comac Medical Expand Transatlantic Collaboration in Women’s Health
06.27.18
Durham, North Carolina and Sofia, Bulgaria. Health Decisions, Inc., the leading US full-service women’s health specialty CRO and Comac Medical, a full-service CRO/SMO operating in 24 European countries, today announced an expansion of their strategic alliance to conduct women’s health clinical trials in the United States, Western and Central and Eastern Europe. “Health Decisions is pleased to strengthen its strategic women’s health alliance with our colleagues at Comac Medical,” stated Health Decisions’ Chief Executive Officer Patrick Phillips, BSc (Hons), D.Phil. “The Health Decisions/Comac Medical alliance provides sponsors of women’s health trials with extensive therapeutic and operational expertise and access to hundreds of investigational women’s health sites in the United States and Europe. These regions provide care for hundreds of millions of women and generate approximately two-thirds of the revenues of the global biopharmaceutical industry. This strategic alliance will enable Health Decisions to fulfill its mission of improving healthcare outcomes for women worldwide and assisting sponsors who share that goal.” Read Full Release
COTA
Cota Founder and Executive Chairman to Present at the Vatican’s Unite to Cure Conference
04.27.18
Cota Inc., a real-world data and analytics company bridging precision medicine to population health, today announced its founder and executive chairman, Andrew Pecora, M.D., will speak today, April 27 at the Fourth International Vatican Conference, Unite to Cure: A Global Health Care Initiative, which is being held from April 26-28 at the Aula Nuova del Sinodo in Vatican City. The event will build on the current global health care movement and unite world leaders across all disciplines to engage in powerful conversations about how science, technology and 21st century medicine will impact culture and society. Read Full Release
COTA
HIMSS18: Interview with Stuart Goldberg, M.D. | Cota | Precision Payment
03.29.18
On this episode we talk with Stuart Goldberg, MD, Chief Scientific Officer at Cota. Dr. Goldberg tells us all about Cota’s physician-led journey to organize and classify real-world evidence about every type of cancer. This effort led to something they call the Cota Nodal Address (CNA), and it’s enabling health systems to get very specific about the types of patients they’re treating, the costs associated with them, and the outcomes being achieved. This apples-to-apples comparison allows Cota to identify variation and address it in ways that are beneficial to the provider, payer and patient. It enables a concept Dr. Goldberg calls “Precision Payment”, which in turn enables proper bundled payment design, and precision medicine. Read Full Release
COTA
Beyond Flatiron: The Rising Power Of Oncology Clinical Data Companies
03.10.18
First, given that (as Andrew Matzkin of Health Advances observed) the Flatiron transaction is “putting smiles on a lot of faces,” what other emerging oncology clinical data companies might soon be in play? And second, more fundamentally, what are the implications of the rise of these types of companies – for both pharma and for healthcare? Read Full Release
COTA
Cota Announces $40 Million Series C Financing to Advance its Cota Nodal Address™ Classification System and Real-World Evidence and Analytics Platforms
02.21.18
Cota Inc., a healthcare real-world evidence and data analytics company bridging precision medicine to population health, today announced the completion of a Series C round of financing led by IQVIA (NYSE: IQV) with major participation by EW Healthcare Partners. Cota will leverage this funding to scale its solutions across healthcare providers, payers and life sciences companies. The funding will also advance its proprietary Cota Nodal Address™ (CNA) system, a powerful and unique precision disease classification system built on its comprehensive real-world data set. Memorial Sloan Kettering Cancer Center also participated in the round, along with existing Cota investors which include, Boston Millennia Partners, Horizon Blue Cross Blue Shield of New Jersey, Hackensack Meridian Health and Atoc Holdings. Read Full Release
MedAptus
MedAptus Named 2018 Top-Ranked Mobile Charge Capture Platfrom by KLAS Research
02.01.18
For the seventh time in eight years, MedAptus® has been named the Category Leader in the Mobile Charge Capture segment in the “2018 Best in KLAS Awards: Software & Services” report. The award recognizes the performance of its CHARGE PRO software product, a charge capture, management and reconciliation that improves financial performance for physicians and hospitals by accurately converting billable services into ICD-10 codes quickly and easily. The company’s top-ranking score of 91.9 reflects feedback from customers across measures evaluating vendor performance data and overall satisfaction. Read Full Release
Bivarus
Press Ganey Acquires Bivarus, Leader in Dynamic Survey Technology
01.16.18
Press Ganey today announced the acquisition of Bivarus, a patient-centered analytics company focused on capturing real-time patient and caregiver insights through a patented dynamic survey approach. The addition of Bivarus’ capabilities complements and further expands Press Ganey’s comprehensive suite of solutions designed to help clients improve the overall safety, quality and experience of care. Read Full Release
Boston Millennia Partners
Odyssey Logistics & Technology Expands Chicago Area Footprint to Better Serve Customer Capacity Issues
11.28.17
Danbury, Conn. (Nov. 28, 2017) – Odyssey Logistics & Technology Corporation (Odyssey) today announced that its subsidiary Linden Bulk Transportation LLC has recently expanded its bulk transportation footprint in Joliet, Illinois. The new location positions Odyssey to offer its customers additional capacity and services in the greater Chicago and Midwest region. Read Full Release
Arthrosurface
Arthrosurface Acquires An Acellular Dermal Technology From WASAS
10.30.17
Arthrosurface, Inc. announced today that it has completed the acquisition of an acellular dermal stabilization device technology, including the intellectual property rights to and associated with this technology, from WASAS, LLC based in Fort Lauderdale, Florida. Arthrosurface plans to use this technology to develop and market a platform of novel methods to be used to correct orthopedic challenges in multiple therapeutic areas. Read Full Release
Odyssey Logistics & Technology
Odyssey Logistics & Technology Receives Equity Investment from The Jordan Company
08.30.17
Odyssey Logistics & Technology Corporation (Odyssey), a leading global logistics provider, announced today that an affiliate of The Jordan Company has signed a definitive agreement to become the new majority shareholder in Odyssey. Read Full Release
Bivarus
Bivarus and Community Oncology Alliance Collaborate to Improve Oncology Patient Experience
08.29.17
Bivarus, a patient-centered analytics company, has formed a partnership with the Community Oncology Alliance (COA) to help its member practices across the country improve patient experiences. COA members can now utilize Bivarus’ survey platform to satisfy the Merit-Based Incentive Payment System (MIPS) requirements for reimbursement from the Centers for Medicare & Medicaid Services (CMS). Read Full Release